Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Cardiovascular and Interventional Radiological Society of Europe
OnlineSVC stenting for treatment of malignant obstruction (2021 – CME) – online course

SVC stenting for treatment of malignant obstruction (2021 – CME) – online course

Description

Authors: A. Mahnken and H. Moriarty

Reviewers: A. Basile, V. Bérczi, B. Gebauer, S. Hopf-Jensen and C. Nice

This course corresponds to chapter 2.2.1.3.3 Disease of the superior and inferior vena cava in the European Curriculum and Syllabus for Interventional Radiology.

 

Abstract

Obstruction of the superior vena cava (SVC), in the modern era, occurs most frequently in malignancy, with bronchogenic carcinoma accounting for at least 50% of causes. Presentation may be as a medical emergency, with features of respiratory or CNS depression, or more indolent in nature. The severity and duration of symptoms of SVC obstruction (SVCO) are an important guide to the timing of intervention. Charnsangavej et al. in 1986 described an endovascular approach for the treatment of SVCO. Percutaneous stenting of the SVC is a minimally invasive procedure which allows rapid alleviation of symptoms without interfering with tumour treatment.

 

Learning objectives

  • To learn about pathophysiology and clinical presentation of malignant SVC obstruction
  • To learn about techniques of SVC stenting
  • To learn about patient management and post-procedural care in patients with malignant SVC obstruction

 

Further information

This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for Interventional Radiology and corresponds to chapter 2.2.1.3.3 Disease of the superior and inferior vena cava.

The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around one hour and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 1 European CME credit (ECMEC).

The acquired CME Certificate will be available in the myCIRSE area under CIRSE Academy.

The enrolment period of this course is linked to the validity of the All-Access Pass.

Release date: February 2021